CLINICAL TRIALS PROFILE FOR ZYLOPRIM
✉ Email this page to a colleague
All Clinical Trials for ZYLOPRIM
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00175019 ↗ | Allopurinol Versus Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010 | Completed | Takeda | Phase 3 | 2003-07-01 | The purpose of this study is to determine the long-term safety of febuxostat, once daily (QD), compared to allopurinol in reducing serum urate levels in subjects with gout. |
| NCT00241839 ↗ | Uric Acid and Hypertension in African Americans | Completed | University of Florida | Phase 3 | 2005-08-01 | This study will test the hypothesis that the administration of a xanthine oxidase inhibitor (allopurinol) will prevent thiazide-induced hyperuricemia, which will result in better blood pressure (BP) control in African Americans. |
| NCT00430248 ↗ | Efficacy and Safety of Oral Febuxostat in Participants With Gout | Completed | Takeda | Phase 3 | 2007-02-01 | The purpose of this study is to compare the efficacy and safety of febuxostat, once Daily (QD), to allopurinol in subjects with hyperuricemia and gout. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ZYLOPRIM
Condition Name
Clinical Trial Locations for ZYLOPRIM
Trials by Country
Clinical Trial Progress for ZYLOPRIM
Clinical Trial Phase
Clinical Trial Sponsors for ZYLOPRIM
Sponsor Name
